...
首页> 外文期刊>Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society >Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations.
【24h】

Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations.

机译:使用局部骨髓源性干细胞给药的新兴疗法可改善严重放射灼伤的伤口修复。

获取原文
获取原文并翻译 | 示例
           

摘要

The therapeutic management of severe radiation burns remains a challenging issue today. Conventional surgical treatment including excision, skin autograft, or flap often fails to prevent unpredictable and uncontrolled extension of the radiation-induced necrotic process. In a recent very severe accidental radiation burn, we demonstrated the efficiency of a new therapeutic approach combining surgery and local cellular therapy using autologous mesenchymal stem cells (MSC), and we confirmed the crucial place of the dose assessment in this medical management. The patient presented a very significant radiation lesion located on the arm, which was first treated by several surgical procedures: iterative excisions, skin graft, latissimus muscle dorsi flap, and forearm radial flap. This conventional surgical therapy was unfortunately inefficient, leading to the use of an innovative cell therapy strategy. Autologous MSC were obtained from three bone marrow collections and were expanded according to a clinical-grade protocol using platelet-derived growth factors. A total of five local MSC administrations were performed in combination with skin autograft. After iterative local MSC administrations, the clinical evolution was favorable and no recurrence of radiation inflammatory waves occurred during the patient's 8-month follow-up. The benefit of this local cell therapy could be linked to the "drug cell" activity of MSC by modulating the radiation inflammatory processes, as suggested by the decrease in the C-reactive protein level observed after each MSC administration. The success of this combined treatment leads to new prospects in the medical management of severe radiation burns and more widely in the improvement of wound repair.
机译:如今,严重放射灼伤的治疗管理仍然是一个具有挑战性的问题。包括切除,皮肤自体移植或皮瓣在内的常规外科手术治疗通常无法防止辐射诱发的坏死过程的不可预测和不受控制的扩展。在最近发生的一次非常严重的意外放射性烧伤中,我们证明了使用自体间充质干细胞(MSC)结合外科手术和局部细胞疗法的新型治疗方法的效率,并且我们确认了剂量评估在这种医疗管理中的关键地位。该患者手臂上有一个非常明显的放射损伤,首先通过几种外科手术治疗:反复切除,植皮,背阔肌背阔肌皮瓣和前臂radial骨皮瓣。不幸的是,这种常规的手术疗法效率低下,导致使用了创新的细胞疗法策略。从三个骨髓收集物中获得自体MSC,并根据临床级方案使用血小板衍生的生长因子进行扩增。结合皮肤自体移植总共进行了五次局部MSC给药。经过局部MSC反复给药后,临床进展良好,并且在患者的8个月随访期间未发生放射性炎症波的复发。这种局部细胞疗法的好处可以通过调节放射炎症过程而与MSC的“药物细胞”活性联系起来,正如每次MSC给药后观察到的C反应蛋白水平降低所表明的那样。这种联合治疗的成功为重度放射性烧伤的医疗管理带来了新的前景,并且在伤口修复的改善方面更为广泛。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号